Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-HCV Genome polyprotein Antibody (D32.10)

Catalog #:   RVV09201 Specific References (49) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: ELISA, Neutralization
Expression system: Mammalian Cells
Overview

Catalog No.

RVV09201

Expression system

Mammalian Cells

Species reactivity

Hepatitis C virus genotype 1a (isolate 1) (HCV)

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

Genome polyprotein

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P26664

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

D32.10

Data Image
  • SDS-PAGE
    SDS PAGE for HCV Genome polyprotein Antibody (D32.10)
References

Inhibition of the binding of HCV serum particles to human hepatocytes by E1E2-specific D32.10 monoclonal antibody. PMID: 19697405

Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral response to therapy in patients infected with hepatitis C virus. PMID: 20890942

Structural and functional characterization of the single-chain Fv fragment from a unique HCV E1E2-specific monoclonal antibody. PMID: 24021643

Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope. PMID: 12882983

Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity. PMID: 2173704

Enveloped particles in the serum of chronic hepatitis C patients. PMID: 15892956

Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes. PMID: 21520209

Impact of pesticide polarity and lipid phase dimensions on the bioaccessibility of pesticides in agricultural produce consumed with model fatty foods. PMID: 32697245

Expression of E1E2 on hepatitis C RNA-containing particles released from primary cultured human hepatocytes derived from infected cirrhotic livers. PMID: 20689310

Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys., PMID:27795428

A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies., PMID:26819308

Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins., PMID:25820616

Hallmarks of hepatitis C virus in equine hepacivirus., PMID:25210167

Expression and characterization of Escherichia coli derived hepatitis C virus ARFP/F protein., PMID:22670521

Persistent expression of hepatitis C virus non-structural proteins leads to increased autophagy and mitochondrial injury in human hepatoma cells., PMID:22164304

Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies., PMID:20705106

The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product., PMID:19548320

Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain., PMID:18550671

Expression of alternate reading frame protein (F1) of hepatitis C virus in Escherichia coli and detection of antibodies for F1 in Indian patients., PMID:18280797

Mass spectrometric characterization of glycosylation of hepatitis C virus E2 envelope glycoprotein reveals extended microheterogeneity of N-glycans., PMID:18187336

Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein., PMID:14988840

[Cloning of hepatitis C virus open reading frame sequence and non structural protein expressions of the virus]., PMID:12810382

The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling., PMID:12621033

Course and outcome of hepatitis C., PMID:12407573

In search of hepatitis C virus receptor(s)., PMID:11685799

Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame., PMID:11350035

Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations., PMID:10608749

Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex., PMID:10211957

Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b., PMID:10073690

Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture., PMID:9922037

[GB virus-C/hepatitis G virus--discovery, epidemiology, diagnosis and clinical relevance]., PMID:9880826

Natural history and molecular biology of hepatitis G virus/GB virus C., PMID:9741635

Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein., PMID:9657115

Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo., PMID:9581788

Identification and subcellular localization of a 41 kDa, polyprotein 1ab processing product in human coronavirus 229E-infected cells., PMID:9367364

Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease., PMID:9215580

Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A., PMID:8982089

Characterization of a 105-kDa polypeptide encoded in gene 1 of the human coronavirus HCV 229E., PMID:8806502

Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses., PMID:8083956

Detection of the putative E2 protein of hepatitis C virus in human liver., PMID:7519251

NS3 is a serine protease required for processing of hepatitis C virus polyprotein., PMID:7685406

Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens., PMID:7681849

Expression and identification of hepatitis C virus polyprotein cleavage products., PMID:7679746

Hepatitis C: looking at a virus that hasn't been seen., PMID:7686118

Antibodies to a putative hepatitis C virus polyprotein in Japanese patients with chronic liver disease., PMID:1334132

[Fundamental studies of hepatitis C virus: a review]., PMID:1331574

Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes., PMID:1314459

Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts., PMID:1312124

Expression of processed core protein of hepatitis C virus in mammalian cells., PMID:1709694

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-HCV Genome polyprotein Antibody (D32.10) [RVV09201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only